View All News
Recently processed articles from Tagesschau broadcasts with AI sentiment analysis
Tipp: You can filter by general article sentiment and specific party reaction separately. E.g., find negative news where AfD reacted positively.
Filter
BioNTech acquires CureVac for cancer research
BioNTech plans to acquire CureVac to enhance its expertise in cancer medicine. The deal is expected to be completed in 2025 and involves a stock exchange.
Note & Thanks
A big thank-you to Tagesschau. This project analyzes and visualizes publicly available content from Tagesschau via their official api2u interface.
We do not store or republish any original content (text, images, or video). Instead, we offer our own summaries, sentiment analysis, and topic insights, always with a direct link to the original article on tagesschau.de.
This is a non-commercial project, operating within the public access guidelines. We are not affiliated with ARD or Tagesschau, but we greatly value their public service and high-quality journalism.
Gefällt Ihnen dieses Projekt?